The biased nucleotide composition of HIV-1 triggers type I interferon response and correlates with subtype D increased pathogenicity

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Vabret, Nicolas ^a   Bailly Bechet, Marc ^b   Najburg, Valérie ^a   Müller Trutwin, Michaela ^a   Verrier, Bernard ^b   Tangy, Frédéric ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ARTICLE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INNATE IMMUNITY; NUCLEIC ACID STRUCTURE; NUCLEOTIDE SEQUENCE; RNA SEQUENCE; STRAIN DIFFERENCE; STRUCTURE ACTIVITY RELATION; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE;

BASE COMPOSITION; CELL LINE; GENES, VIRAL; GENOME, VIRAL; HIV-1; HUMANS; INTERFERON TYPE I; RNA, VIRAL;

EID: 84859991845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033502     Document Type: Article

References (37)

1. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE, (2002) CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 8: 319-323.
2. Pandrea I, Sodora DL, Silvestri G, Apetrei C, (2008) Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts. Trends Immunol 29: 419-428.
3. Sodora DL, Silvestri G, (2008) Immune activation and AIDS pathogenesis. AIDS 22: 439-446.
4. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, et al. (2009) Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15: 861-865.
5. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, et al. (2009) Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 119: 3544-3555.
6. Harris LD, Tabb B, Sodora DL, Paiardini M, Klatt NR, et al. (2010) Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 84: 7886-7891.
7. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, et al. (2010) Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue. Cell 143: 789-801.
8. Yoneyama M, Fujita T, (2010) Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20: 4-22.
9. Diebold S, (2010) Innate recognition of viruses. Immunol Lett 128: 17-20.
10. Rehwinkel J, (2010) Exposing viruses: RNA patterns sensed by RIG-I-like receptors. J Clin Immunol 30: 491-495.
11. Bauer S, Muller T, Hamm S, (2009) Pattern recognition by Toll-like receptors. Adv Exp Med Biol 653: 15-34.
12. Manel N, Hogstad B, Wang Y, Levy DE, Unutmaz D, et al. (2010) A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467: 214-217.
13. Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, et al. (2011) Innate sensing of HIV-infected cells. PLoS Pathog 7: e1001284.
14. Beignon AS, McKenna K, Skoberne M, Manches O, DaSilva I, et al. (2005) Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 115: 3265-3275.
15. Mandl JN, Barry AP, Vanderford TH, Kozyr N, Chavan R, et al. (2008) Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 14: 1077-1087.
16. Nascimbeni M, Perie L, Chorro L, Diocou S, Kreitmann L, et al. (2009) Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. Blood 113: 6112-6119.
17. Berkhout B, Grigoriev A, Bakker M, Lukashov VV, (2002) Codon and amino acid usage in retroviral genomes is consistent with virus-specific nucleotide pressure. AIDS Res Hum Retroviruses 18: 133-141.
18. Berkhout B, van Hemert FJ, (1994) The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins. Nucleic Acids Res 22: 1705-1711.
19. Vartanian JP, Meyerhans A, Sala M, Wain-Hobson S, (1994) G->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription. Proc Natl Acad Sci U S A 91: 3092-3096.
20. Deforche K, Camacho R, Laethem KV, Shapiro B, Moreau Y, et al. (2007) Estimating the relative contribution of dNTP pool imbalance and APOBEC3G/3F editing to HIV evolution in vivo. J Comput Biol 14: 1105-1114.
21. Bishop KN, Holmes RK, Sheehy AM, Malim MH, (2004) APOBEC-mediated editing of viral RNA. Science 305: 645.
22. Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, et al. (2009) HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 5: e1000414.
23. Mulder LC, Harari A, Simon V, (2008) Cytidine deamination induced HIV-1 drug resistance. Proc Natl Acad Sci U S A 105: 5501-5506.
24. van Hemert FJ, Berkhout B, (1995) The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J Mol Evol 41: 132-140.
25. Easterbrook PJ, Smith M, Mullen J, O'Shea S, Chrystie I, et al. (2010) Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc 13: 4.
26. Kaleebu P, French N, Mahe C, Yirrell D, Watera C, et al. (2002) Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda. J Infect Dis 185: 1244-1250.
27. Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, et al. (2010) HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 54: 180-184.
28. Bousheri S, Burke C, Ssewanyana I, Harrigan R, Martin J, et al. (2009) Infection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis. J Acquir Immune Defic Syndr 52: 548-552.
29. Meier A, Alter G, Frahm N, Sidhu H, Li B, et al. (2007) MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 81: 8180-8191.
30. Chiu YH, Macmillan JB, Chen ZJ, (2009) RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138: 576-591.
31. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr, (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454: 523-527.
32. Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, et al. (2010) RIG-I Mediated Antiviral Signalling is Inhibited in HIV-1 Infection by a Protease-Mediated Sequestration of RIG-I. J Virol.
33. Malathi K, Dong B, Gale M Jr, Silverman RH, (2007) Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 448: 816-819.
34. Sauter D, Schindler M, Specht A, Landford WN, Munch J, et al. (2009) Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6: 409-421.
35. Brenchley JM, Silvestri G, Douek DC, (2010) Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 32: 737-742.
36. Silvestri G, Fedanov A, Germon S, Kozyr N, Kaiser WJ, et al. (2005) Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol 79: 4043-4054.
37. Smith HC, (2011) APOBEC3G: a double agent in defense. Trends Biochem Sci.